Although activation of NRF2, a master regulator of antioxidant responses, in cancer can be beneficial, the fumarate-induced stabilization of NRF2 in HLRCC facilitates tumor growth and survival (34). This evidence concerns the gene NFE2L2 and hereditary leiomyomatosis and renal cell cancer.